Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lotti

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonistR S Chang, V J Lotti
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1970
Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitorsV J Lotti, C C Porter
Life Sciences|August 10, 1981
Solubilization of angiotensin II receptors in bovine adrenal cortexR S Chang, V J Lotti
Archives Internationales De Pharmacodynamie Et De Therapie|December 1, 1973
Histamine: intraventricular injection suppresses ingestive behavior of the catB V Clineschmidt, V J Lotti
European Journal of Pharmacology|March 21, 1989
A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260V J Lotti, R S Chang
European Journal of Pharmacology|November 19, 1982
alpha 2-Adrenergic agonist and antagonist activity of the respective (-)-and (+)-enantiomers of 6-ethyl-9-oxaergoline (EOE)V J Lotti, D A Taylor
British Journal of Pharmacology|February 1, 1974
Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responsesB V Clineschmidt, V J Lotti
Journal of Autonomic Pharmacology|September 1, 1982
Characterization of the adrenoreceptor activities of isoprenaline in the field stimulated rat vas deferens: selective supersensitivity to beta 2-mediated responses following reserpine treatmentV J Lotti, D Cerino, P Kling
European Journal of Pharmacology|October 22, 1982
High and low (Gpp(NH)p-sensitive) affinity sites for beta 2-adrenergic blockers as antagonists of isoproterenol in the field-stimulated rat vas deferensV J Lotti, P Kling, D Cerino
Journal of Biological Regulators and Homeostatic Agents|July 14, 2017
Spontaneous retrospective clinical evaluation of a new phytoestrogen-based cosmetic gel cream on postmenopausal women’s skinP Amori, J Lotti, T Lotti, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonistR S Chang, V J Lotti
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1970
Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitorsV J Lotti, C C Porter
Life Sciences|August 10, 1981
Solubilization of angiotensin II receptors in bovine adrenal cortexR S Chang, V J Lotti
Archives Internationales De Pharmacodynamie Et De Therapie|December 1, 1973
Histamine: intraventricular injection suppresses ingestive behavior of the catB V Clineschmidt, V J Lotti
European Journal of Pharmacology|March 21, 1989
A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260V J Lotti, R S Chang
European Journal of Pharmacology|November 19, 1982
alpha 2-Adrenergic agonist and antagonist activity of the respective (-)-and (+)-enantiomers of 6-ethyl-9-oxaergoline (EOE)V J Lotti, D A Taylor
British Journal of Pharmacology|February 1, 1974
Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responsesB V Clineschmidt, V J Lotti
Journal of Autonomic Pharmacology|September 1, 1982
Characterization of the adrenoreceptor activities of isoprenaline in the field stimulated rat vas deferens: selective supersensitivity to beta 2-mediated responses following reserpine treatmentV J Lotti, D Cerino, P Kling
European Journal of Pharmacology|October 22, 1982
High and low (Gpp(NH)p-sensitive) affinity sites for beta 2-adrenergic blockers as antagonists of isoproterenol in the field-stimulated rat vas deferensV J Lotti, P Kling, D Cerino
Journal of Biological Regulators and Homeostatic Agents|July 14, 2017
Spontaneous retrospective clinical evaluation of a new phytoestrogen-based cosmetic gel cream on postmenopausal women’s skinP Amori, J Lotti, T Lotti, et al.
Pageof 13